NO834695L - Nye farmakologisk aktive pyrazolopyridiner og fremgangsmaate for deres fremstilling - Google Patents

Nye farmakologisk aktive pyrazolopyridiner og fremgangsmaate for deres fremstilling

Info

Publication number
NO834695L
NO834695L NO834695A NO834695A NO834695L NO 834695 L NO834695 L NO 834695L NO 834695 A NO834695 A NO 834695A NO 834695 A NO834695 A NO 834695A NO 834695 L NO834695 L NO 834695L
Authority
NO
Norway
Prior art keywords
pyrazolopyridines
procedures
preparation
pharmacological active
new pharmacological
Prior art date
Application number
NO834695A
Other languages
English (en)
Other versions
NO160367C (no
NO160367B (no
Inventor
Giorgio Winters
Original Assignee
Lepetit Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lepetit Spa filed Critical Lepetit Spa
Publication of NO834695L publication Critical patent/NO834695L/no
Publication of NO160367B publication Critical patent/NO160367B/no
Publication of NO160367C publication Critical patent/NO160367C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
NO834695A 1982-12-20 1983-12-19 Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrazolopyridiner. NO160367C (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8236131 1982-12-20

Publications (3)

Publication Number Publication Date
NO834695L true NO834695L (no) 1984-06-21
NO160367B NO160367B (no) 1989-01-02
NO160367C NO160367C (no) 1989-04-12

Family

ID=10535093

Family Applications (1)

Application Number Title Priority Date Filing Date
NO834695A NO160367C (no) 1982-12-20 1983-12-19 Analogifremgangsmaate for fremstilling av terapeutisk aktive pyrazolopyridiner.

Country Status (19)

Country Link
US (1) US4954508A (no)
EP (1) EP0114273B1 (no)
JP (1) JPH0660181B2 (no)
KR (1) KR890002227B1 (no)
AT (1) ATE69227T1 (no)
AU (1) AU574654B2 (no)
DE (1) DE3382452D1 (no)
DK (1) DK582083A (no)
ES (2) ES8601987A1 (no)
FI (1) FI76337C (no)
GR (1) GR79111B (no)
IE (1) IE57305B1 (no)
IL (1) IL70445A (no)
MY (1) MY101250A (no)
NO (1) NO160367C (no)
NZ (1) NZ206626A (no)
PH (1) PH20896A (no)
PT (1) PT77850B (no)
ZA (1) ZA839092B (no)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5965089A (ja) * 1982-10-05 1984-04-13 Shionogi & Co Ltd ジヒドロピラゾロ〔３，４−ｂ〕ピリジン誘導体およびその製造法
US4873334A (en) * 1982-10-05 1989-10-10 Shionogi & Co., Ltd. 4,7-dihydropyrazolo(3,4-b) pyridine derivatives
JPS60197685A (ja) * 1984-03-19 1985-10-07 Shionogi & Co Ltd ４，７―ジヒドロピラゾロ［３，４―ｂ］ピリジン誘導体とその製造法
JPS6056979A (ja) * 1983-09-08 1985-04-02 Shionogi & Co Ltd ４，７−ジヒドロピラゾロ〔３，４−ｂ〕ピリジン誘導体およびその製造法
US4918074A (en) * 1984-03-12 1990-04-17 Yoshitomi Pharmaceutical Industries, Ltd. Polyazaheterocycle compounds
US4916140A (en) * 1988-09-28 1990-04-10 Merrell Dow Pharmaceuticals Inc. Antiepileptic pyrazolopyridines
WO2002062795A2 (en) * 2001-02-02 2002-08-15 Mitsubishi Pharma Corporation Dihydropyrazolopyridine compounds and pharmaceutical use thereof
US6977262B2 (en) 2001-02-02 2005-12-20 Mitsubishi Pharma Corporation Dihydropyrazolopyridine compounds and pharmaceutical use thereof
CN1823067A (zh) * 2003-06-13 2006-08-23 赞塔里斯有限公司 具有抑制磷脂酰肌醇3－激酶活性的化合物及其使用方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3773778A (en) * 1972-01-24 1973-11-20 Squibb & Sons Inc Sulfur derivatives of pyrazolo (3,4-b)pyridines
DE2356684A1 (de) * 1972-11-15 1974-05-16 Heyden Chem Fab Neue 4-aminoderivate von pyrazolo (3,4-b)pyridin-5-carboxamiden
US4038283A (en) * 1975-04-30 1977-07-26 E. R. Squibb & Sons, Inc. 4-Alkoxy or hydroxy derivatives of 2H-pyrazolo[3,4-b]pyridine-5-carboxylic acids and esters
GB1568399A (en) * 1975-10-16 1980-05-29 Squibb & Sons Inc Pyrazolo pyridine derivatives
US4020072A (en) * 1976-05-04 1977-04-26 E. R. Squibb & Sons, Inc. 5-Aminomethyl-1H-pyrazolo[3,4-b]pyridines
NZ201395A (en) * 1981-07-30 1987-02-20 Bayer Ag Pharmaceutical compositions containing 1,4-dihydropyridines and certain of these dihydropyridines
JPS5965089A (ja) * 1982-10-05 1984-04-13 Shionogi & Co Ltd ジヒドロピラゾロ〔３，４−ｂ〕ピリジン誘導体およびその製造法

Also Published As

Publication number Publication date
DK582083A (da) 1984-06-21
PH20896A (en) 1987-05-27
IL70445A (en) 1988-12-30
NO160367C (no) 1989-04-12
PT77850A (en) 1984-01-01
IE57305B1 (en) 1992-07-15
EP0114273A1 (en) 1984-08-01
ES8506016A1 (es) 1985-06-16
IL70445A0 (en) 1984-03-30
DK582083D0 (da) 1983-12-16
ES528152A0 (es) 1985-11-16
FI834661A (fi) 1984-06-21
JPH0660181B2 (ja) 1994-08-10
ATE69227T1 (de) 1991-11-15
NZ206626A (en) 1986-11-12
ES8601987A1 (es) 1985-11-16
JPS59118786A (ja) 1984-07-09
ZA839092B (en) 1984-07-25
FI76337B (fi) 1988-06-30
EP0114273B1 (en) 1991-11-06
KR890002227B1 (ko) 1989-06-24
FI76337C (fi) 1988-10-10
FI834661A0 (fi) 1983-12-19
KR840007000A (ko) 1984-12-04
DE3382452D1 (de) 1991-12-12
NO160367B (no) 1989-01-02
PT77850B (en) 1986-05-08
US4954508A (en) 1990-09-04
AU2227083A (en) 1984-06-28
AU574654B2 (en) 1988-07-14
MY101250A (en) 1991-08-17
IE832988L (en) 1984-06-20
GR79111B (no) 1984-10-02
ES532124A0 (es) 1985-06-16

Similar Documents

Publication Publication Date Title
FI883807A (fi) Menetelmä farmakologisesti aktiivisten 7-(3-substituoitu-1-pyrrolidinyyli)-1-syklopropyyli-1,4-dihydro-4-okso-1,8-naftyridiini-3-karboksyylihappojohdannaisten valmistamiseksi
NO163131C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive pyridinderivater.
HUT46657A (en) Process for producing antitumour pharmaceutical compositions comprising sulfonyl-urea derivatives as active ingredient
NO170155C (no) Analogifremgangsmaate til fremstilling av terapeutisk aktive substituerte tieno(3,4-d)imidazolderivater
HUT35659A (en) Process for producing 4-amino-methylene-chromane- and-chromene-derivatives and pharmaceutical compositions containing them as active agents
NO176713C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 4-aminopyridinderivater
EP0104522A3 (en) New pyrazolo(3,4-b)pyridine derivatives and process for producing them
NO834695L (no) Nye farmakologisk aktive pyrazolopyridiner og fremgangsmaate for deres fremstilling
FI93444B (fi) Menetelmä terapeuttisesti aktiivisten dihydropyridiinijohdannaisten valmistamiseksi
ES8106306A1 (es) Un procedimiento para la preparacion de derivados de triazo-lopiridazina
FI871087A0 (fi) Menetelmä terapeuttisesti aktiivisten 1,2,3,4-tetrahydro-3-karbamoyyli-2-tiokso/okso-5-pyrimidiinikarboksyylihappojohdannaisten valmistamiseksi
NO850564L (no) Fremgangsmaate for fremstilling av terapeutisk aktive (2-okso-1,2,3,5-tetrahydroimidazo 2,1-b kinazolinyl) oksyalkylamider
IL75874A0 (en) Naphthyl analogs of mevalonolactone and derivatives thereof,their production and pharmaceutical compositions containing them
DK351484A (da) Pyrazolo(3,4,5-kl)acridinforbindelser, deres fremstilling og anvendelse
FI93454B (fi) Menetelmä terapeuttisesti aktiivisten tiasykloalkeno/3,2-b/pyridiinien valmistamiseksi
IT8522597A0 (it) Derivati della piridina, procedimento per la loro preparazione di composizioni terapeutiche contenenti detti derivati.
FR2592653A1 (fr) Derives de chromene, procede d'obtention et compositions pharmaceutiques.
NO175099C (no) Analogifremgangsmåte for fremstilling av terapeutisk aktive 1,3,5-tritianderivater
YU83284A (en) Process for making 2-alkylthio-1aminoalkyl-2-pyroline-3-carbonitrile